Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -61.62% | 656.83% | -152.83% | 4.23% | -70.05% |
| Total Depreciation and Amortization | -- | -- | 293.57% | -196.39% | -- |
| Total Amortization of Deferred Charges | -- | -- | 292.47% | -270.04% | -- |
| Total Other Non-Cash Items | 204.04% | -222.71% | 210.22% | -178.72% | 204.03% |
| Change in Net Operating Assets | -- | -- | -119.23% | 201.16% | -- |
| Cash from Operations | 112.91% | -191.90% | 224.70% | 18.05% | 134.80% |
| Capital Expenditure | -20.23% | 29.15% | -27.23% | -1.73% | 23.52% |
| Sale of Property, Plant, and Equipment | 3,755.61% | -88.62% | 319.07% | -53.96% | 741.44% |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -630.25% | 64.05% | -1,695.07% | 97.67% | -9,501.19% |
| Cash from Investing | -442.56% | 57.63% | -427.75% | 90.94% | -1,172.27% |
| Total Debt Issued | -9.76% | 196.86% | 0.85% | -20.43% | -65.58% |
| Total Debt Repaid | 19.54% | -27.18% | -155.66% | 51.02% | 39.47% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -685.13% | 89.20% | -192.15% | 76.80% | -1,371.20% |
| Other Financing Activities | 385.05% | -133.93% | 185.49% | -418.60% | -425.99% |
| Cash from Financing | -12.48% | 163.66% | -20,303.91% | 99.42% | -168.72% |
| Foreign Exchange rate Adjustments | -113.64% | 194.42% | 189.99% | -60.09% | -24.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.64% | -505.82% | -8.31% | 124.90% | -159.60% |